Proceedings of the National Academy of Sciences · 2015 · 208 citations · 14 references
Life SciencesImmunologyPharmacotherapyImmunoregulationImmunotherapyTargeted Drug DeliveryAngiogenesisAngiogenesis In CancerGrowth Factor SignalingGrowth Factor TherapyTargeted Cancer TherapyTuberculosis PharmacotherapyAngiogenic ModulationTherapeutic Target IdentificationTumor Vascular NormalizationVascular Endothelial Growth FactorVascular Endothelial Growth Factor InhibitionVascular Endothelial Growth Factor InhibitorsVegf Pathway InhibitionVegfr Inhibitors
Tuberculosis (TB) causes almost 2 million deaths annually, and an increasing number of patients are resistant to existing therapies. Patients who have TB require lengthy chemotherapy, possibly because of poor penetration of antibiotics into granulomas where the bacilli reside. Granulomas are morphologically similar to solid cancerous tumors in that they contain hypoxic microenvironments and can be highly fibrotic. Here, we show that TB-infected rabbits have impaired small molecule distribution into these disease sites due to a functionally abnormal vasculature, with a low-molecular-weight tracer accumulating only in peripheral regions of granulomatous lesions. Granuloma-associated vessels are morphologically and spatially heterogeneous, with poor vessel pericyte coverage in both human and experimental rabbit TB granulomas. Moreover, we found enhanced VEGF expression in both species. In tumors, antiangiogenic, specifically anti-VEGF, treatments can "normalize" their vasculature, reducing hypoxia and creating a window of opportunity for concurrent chemotherapy; thus, we investigated vessel normalization in rabbit TB granulomas. Treatment of TB-infected rabbits with the anti-VEGF antibody bevacizumab significantly decreased the total number of vessels while normalizing those vessels that remained. As a result, hypoxic fractions of these granulomas were reduced and small molecule tracer delivery was increased. These findings demonstrate that bevacizumab treatment promotes vascular normalization, improves small molecule delivery, and decreases hypoxia in TB granulomas, thereby providing a potential avenue to improve delivery and efficacy of current treatment regimens.
14
Ricky T. Tong, Yves Boucher, Sergey V. Kozin et al. · Cancer Research · 2004 · 1.2K citations · Full text
Medicine, Cancer Biology, Oncology +17
Strategies for advancing cancer nanomedicine
Vikash P. Chauhan · Nature Materials · 2013 · 813 citations · Full text
Delivery of molecular and cellular medicine to solid tumors
Advanced Drug Delivery Reviews · 2012 · 774 citations · Full text
Medicine, Cancer Biology, Oncology +17
Tuberculous Granulomas Are Hypoxic in Guinea Pigs, Rabbits, and Nonhuman Primates
Laura E. Via, Philana Ling Lin, Sonja M. Ray et al. · Infection and Immunity · 2008 · 649 citations · Full text